Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy

Triple negative breast cancer (TNBC) is defined by a lack of ER, PgR, and HER2 expression, and to date there have been no significant advances in treatment by targeted therapies against those molecules. Therefore, primary systemic therapy (PST) followed by surgery is the standard therapy for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanke, Yasuyuki, Saito, Motonobu, Abe, Noriko, Saito, Katsuharu, Goto, Akiteru, Ohtake, Tohru, Murakami, Yoshinori, Kono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313031/
https://www.ncbi.nlm.nih.gov/pubmed/30655848
http://dx.doi.org/10.3892/ol.2018.9727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313031/
https://www.ncbi.nlm.nih.gov/pubmed/30655848
http://dx.doi.org/10.3892/ol.2018.9727

Ejemplares similares